API Suppliers
US DMFs Filed
CEP/COS Certifications
JDMFs Filed
EU WC
Listed Suppliers
USA (Orange Book)
Europe
Canada
Australia
South Africa
Uploaded Dossiers
U.S. Medicaid
Annual Reports
15
PharmaCompass offers a list of Esomeprazole Magnesium API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Esomeprazole Magnesium manufacturer or Esomeprazole Magnesium supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Esomeprazole Magnesium manufacturer or Esomeprazole Magnesium supplier.
PharmaCompass also assists you with knowing the Esomeprazole Magnesium API Price utilized in the formulation of products. Esomeprazole Magnesium API Price is not always fixed or binding as the Esomeprazole Magnesium Price is obtained through a variety of data sources. The Esomeprazole Magnesium Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Esomeprazole Potassium manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Esomeprazole Potassium, including repackagers and relabelers. The FDA regulates Esomeprazole Potassium manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Esomeprazole Potassium API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Esomeprazole Potassium manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Esomeprazole Potassium supplier is an individual or a company that provides Esomeprazole Potassium active pharmaceutical ingredient (API) or Esomeprazole Potassium finished formulations upon request. The Esomeprazole Potassium suppliers may include Esomeprazole Potassium API manufacturers, exporters, distributors and traders.
click here to find a list of Esomeprazole Potassium suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Esomeprazole Potassium DMF (Drug Master File) is a document detailing the whole manufacturing process of Esomeprazole Potassium active pharmaceutical ingredient (API) in detail. Different forms of Esomeprazole Potassium DMFs exist exist since differing nations have different regulations, such as Esomeprazole Potassium USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Esomeprazole Potassium DMF submitted to regulatory agencies in the US is known as a USDMF. Esomeprazole Potassium USDMF includes data on Esomeprazole Potassium's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Esomeprazole Potassium USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Esomeprazole Potassium suppliers with USDMF on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Esomeprazole Potassium Drug Master File in Japan (Esomeprazole Potassium JDMF) empowers Esomeprazole Potassium API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Esomeprazole Potassium JDMF during the approval evaluation for pharmaceutical products. At the time of Esomeprazole Potassium JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Esomeprazole Potassium suppliers with JDMF on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Esomeprazole Potassium Drug Master File in Korea (Esomeprazole Potassium KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Esomeprazole Potassium. The MFDS reviews the Esomeprazole Potassium KDMF as part of the drug registration process and uses the information provided in the Esomeprazole Potassium KDMF to evaluate the safety and efficacy of the drug.
After submitting a Esomeprazole Potassium KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Esomeprazole Potassium API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Esomeprazole Potassium suppliers with KDMF on PharmaCompass.
A Esomeprazole Potassium CEP of the European Pharmacopoeia monograph is often referred to as a Esomeprazole Potassium Certificate of Suitability (COS). The purpose of a Esomeprazole Potassium CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Esomeprazole Potassium EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Esomeprazole Potassium to their clients by showing that a Esomeprazole Potassium CEP has been issued for it. The manufacturer submits a Esomeprazole Potassium CEP (COS) as part of the market authorization procedure, and it takes on the role of a Esomeprazole Potassium CEP holder for the record. Additionally, the data presented in the Esomeprazole Potassium CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Esomeprazole Potassium DMF.
A Esomeprazole Potassium CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Esomeprazole Potassium CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Esomeprazole Potassium suppliers with CEP (COS) on PharmaCompass.
A Esomeprazole Potassium written confirmation (Esomeprazole Potassium WC) is an official document issued by a regulatory agency to a Esomeprazole Potassium manufacturer, verifying that the manufacturing facility of a Esomeprazole Potassium active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Esomeprazole Potassium APIs or Esomeprazole Potassium finished pharmaceutical products to another nation, regulatory agencies frequently require a Esomeprazole Potassium WC (written confirmation) as part of the regulatory process.
click here to find a list of Esomeprazole Potassium suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Esomeprazole Potassium as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Esomeprazole Potassium API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Esomeprazole Potassium as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Esomeprazole Potassium and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Esomeprazole Potassium NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Esomeprazole Potassium suppliers with NDC on PharmaCompass.
Esomeprazole Potassium Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Esomeprazole Potassium GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Esomeprazole Potassium GMP manufacturer or Esomeprazole Potassium GMP API supplier for your needs.
A Esomeprazole Potassium CoA (Certificate of Analysis) is a formal document that attests to Esomeprazole Potassium's compliance with Esomeprazole Potassium specifications and serves as a tool for batch-level quality control.
Esomeprazole Potassium CoA mostly includes findings from lab analyses of a specific batch. For each Esomeprazole Potassium CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Esomeprazole Potassium may be tested according to a variety of international standards, such as European Pharmacopoeia (Esomeprazole Potassium EP), Esomeprazole Potassium JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Esomeprazole Potassium USP).